Clinical Trial: BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Randomized, Controlled Evaluation of the Safety and Efficacy of a Topical Treatment for Moderate-Severe Facial Acne Vulgaris
Brief Summary: The purpose of this study is to compare the safety and efficacy of formulation BLI1100 to its vehicle in the treatment of moderate-severe acne vulgaris.
Detailed Summary:
Sponsor: Braintree Laboratories
Current Primary Outcome: percent reduction of total acne lesion counts [ Time Frame: 12 weeks ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- Investigator's Global Assessment [ Time Frame: 12 ]Rating of overall facial acne on a 4 point scale (0=clear to 4=severe) performed by a blinded investigator.
- Change in serum chemistry [ Time Frame: 12 weeks ]
Original Secondary Outcome: Same as current
Information By: Braintree Laboratories
Dates:
Date Received: November 11, 2010
Date Started: November 2010
Date Completion:
Last Updated: September 27, 2012
Last Verified: September 2012